Rinvoq™

Read the CMI leaflet (Opens in new tab) for facts you need to know before, during and after taking your medicine.

Listen to the audio transcription of the CMI leaflet.

For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).

Crohns Disease,RINVOQ is indicated for the treatment of adult patients with moderately to severely active Crohns disease, who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biological medicine.Rheumatoid Arthritis,RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to, one or more disease-modifying anti-rheumatic drugs (DMARDs).,RINVOQ may be used as monotherapy or in combination with methotrexate or other conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs).,Psoriatic Arthritis,RINVOQ is indicated for the treatment of moderate to severe active psoriatic arthritis in adult patients who have responded inadequately to, or are intolerant to one or more DMARDs.,RINVOQ may be used as monotherapy or in combination with a non-biological DMARD.,Non-radiographic Axial Spondyloarthritis,RINVOQ is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) change, who have responded inadequately to, or are intolerant to nonsteroidal anti-inflammatory drugs (NSAIDs).,Ankylosing Spondylitis,RINVOQ is indicated for the treatment of adults with active ankylosing spondylitis.,Atopic Dermatitis,RINVOQ is indicated for use in adults and adolescents aged 12 years and above who weigh at least 40 kg, for the treatment of moderate to severe atopic dermatitis which is inadequately controlled with active topical pharmacotherapies and for whom systemic therapy is indicated.,Ulcerative Colitis,RINVOQ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis, who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biological medicine.

Source: ARTG

• Shelf lifetime is 24 Months
• Store below 30 degrees Celsius
• Protect from Moisture

Source: ARTG

Non-composite pack

This medicine contains one component only.

Component

• Tablet, modified release
• Oral
• RINVOQ 15 mg tablets are purple, biconvex oblong in shape with dimensions of 14 x 8 mm and debossed with 'a15' on one side.

Source: ARTG

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.?What is the medicines and poisons schedule?

All medicines and poisons in Australia are categorised by how they are made available to the public. Medicines with a low safety risk are usually less tightly controlled than medicines with a higher safety risk. This system is called ‘scheduling’. You can read more about the scheduling of medicines as well as the different scheduling categories on our Scheduling of medicines and poisons information page.

• 28 tablets
• 7 tablets (starter pack)

Source: ARTG

This medicine was verified as available on the Pharmaceutical Benefits Scheme (PBS) on 1 August 2026, under the following PBS item codes:

• 11979L (Opens in new tab)
• 12624K (Opens in new tab)
• 12625L (Opens in new tab)
• 13350P (Opens in new tab)
• 12831H (Opens in new tab)
• 13343G (Opens in new tab)
• 13768P (Opens in new tab)
• 14125K (Opens in new tab)
• 11989B (Opens in new tab)
• 12835M (Opens in new tab)
• 13256Q (Opens in new tab)
• 12621G (Opens in new tab)
• 12828E (Opens in new tab)
• 13250J (Opens in new tab)
• 12648Q (Opens in new tab)

Ask your pharmacist or doctor about your eligibility

Source: PBS

For the active ingredient: Upadacitinib

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Source: AHT

Healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions (Opens in new tab).